Intravenous thrombolysis in the presence of unruptured intracranial aneurysm: safety, case report and literature review
EANS Academy. Beneš Jr V. 09/25/19; 275387; EP01001
Vladimir Beneš Jr
Vladimir Beneš Jr

Access to this content is reserved for EANS members and attendees of this event. Click here to become an EANS member and gain your access to the full content of the EANS Academy

Discussion Forum (0)
Rate & Comment (0)
Introduction: Intravenous thrombolysis is a proven treatment of acute ischemic stroke. Its complications include intracranial hemorrhage. The presence of an unruptured aneurysm (UIA) can be considered a relative contraindication. The purpose of this study is to assess prevalence of UIAs in patients treated with thrombolysis; assess safety of intravenous thrombolysis in the presence of an UIA; and report a case of fatal aneurysm rupture and analyze similar patients from the literature.
Patients and methods: Retrospective analysis of prospectively collected data of patients undergoing thrombolytic treatment for stroke during 2016-2017. The patients were divided into two groups according to the presence of an UIA (UIA+ and UIA-).
Results: During the study period 294 patients received thrombolytic treatment for stroke, 13 patients harbored an UIA (prevalence 4,4%). There was no significant difference in basic demographic data between the two groups. There was one fatal aneurysm rupture in the UIA+ group, however overall rate of intracranial hemorrhage was not significantly different (7,7% UIA+ and 7,5% UIA-). The rate of favorable outcome at 3 moths was not significantly different (53,8% UIA+ and 52,8% UIA-). Further 8 patients suffering aneurysm rupture after thrombolysis were identified in the literature.
Conclusions: Presence of an aneurysm in patients undergoing thrombolytic treatment does not seem to bear negative impact on outcome and should not be considered a contraindication. Given higher aneurysm prevalence in stroke patients and very high rate of disastrous outcome following rupture after thrombolysis, we call for detailed evaluation of vessel imaging and exclusion of recent sentinel bleeding when an aneurysm is diagnosed.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings